Satellos to Present at Upcoming Virtual Investor Conferences in March and April
March 14 2024 - 7:00AM
Business Wire
Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSX:
MSCL, OTCQB: MSCLF), a public biotech company developing new small
molecule therapeutic approaches to improve the treatment of muscle
diseases and disorders, announced today that Frank Gleeson,
cofounder and CEO of Satellos, will present at the following
investor conferences:
Stifel 2024 Virtual CNS Days Format: Fireside Chat
Date: Wednesday, March 20 at 8:00 a.m. ET
Cantor Virtual Muscular Dystrophy Symposium
Format: Fireside Chat Date: Wednesday, April 3 at
11:30 a.m. ET
The fireside chats will be available via live webcast on the
Events and Presentations page in the Investors section of the
Company’s website and a replay will be available following the
presentation.
About Satellos Bioscience Inc.
Satellos is a publicly traded biotechnology company dedicated to
developing life-improving medicines to treat degenerative muscle
diseases. Satellos has incorporated breakthrough research in muscle
stem cell polarity into a proprietary discovery platform, called
MyoReGenXTM, to identify degenerative muscle diseases where
deficits in this process affect muscle regeneration and are
amenable to therapeutic intervention. With this platform, Satellos
is building a pipeline of novel therapeutics to correct muscle stem
cell polarity and promote the body’s innate muscle repair and
regeneration process. The Company’s lead program is an oral, small
molecule drug candidate in development as a potential
disease-modifying treatment for Duchenne muscular dystrophy.
Satellos is headquartered in Toronto, Ontario. For more
information, visit www.satellos.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240314224723/en/
Investors: Liz Williams, ir@satellos.com Business Development:
Ryan Mitchell, Ph.D., bd@satellos.com Media: Jessica Yingling,
Ph.D., jessica@litldog.com, +1.858.344.8091
Satellos Bioscience (TSX:MSCL)
Historical Stock Chart
From Dec 2024 to Jan 2025
Satellos Bioscience (TSX:MSCL)
Historical Stock Chart
From Jan 2024 to Jan 2025
